MIMPARA

Serial Number 77014804
606

Registration Progress

Application Filed
Oct 5, 2006
Under Examination
Nov 13, 2007
Approved for Publication
Aug 1, 2007
Published for Opposition
Aug 21, 2007
Registered

Trademark Image

MIMPARA

Basic Information

Serial Number
77014804
Filing Date
October 5, 2006
Published for Opposition
August 21, 2007
Abandonment Date
December 13, 2010
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 13, 2010
Classes
005

Rights Holder

Amgen Inc.

03
Address
One Amgen Center Drive
Thousand Oaks, CA 913201799

Ownership History

Amgen Inc.

Original Applicant
03
Thousand Oaks, CA

Amgen Inc.

Owner at Publication
03
Thousand Oaks, CA

Legal Representation

Attorney
Mark I. Feldman, Christina L. Martini, Monica L. Thompson, Keith W. Medansky, Linda Urbanik Johnson, Gina L. Durham, Amy C. Ziegler, Nicole A. Chaudhari and Daniel I. Hwang

USPTO Deadlines

All Deadlines Cleared

All 4 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description
Dec 13, 2010 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Dec 13, 2010 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
May 18, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 17, 2010 EX5G S SOU EXTENSION 5 GRANTED
May 12, 2010 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 26, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 26, 2010 EXT5 S SOU EXTENSION 5 FILED
Nov 6, 2009 EX4G S SOU EXTENSION 4 GRANTED
Nov 4, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 4, 2009 EXT4 S SOU EXTENSION 4 FILED
Apr 9, 2009 EX3G S SOU EXTENSION 3 GRANTED
Apr 8, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 8, 2009 EXT3 S SOU EXTENSION 3 FILED
Sep 30, 2008 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 30, 2008 EX2G S SOU EXTENSION 2 GRANTED
Sep 29, 2008 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 29, 2008 EXT2 S SOU EXTENSION 2 FILED
May 14, 2008 EX1G S SOU EXTENSION 1 GRANTED
Apr 29, 2008 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 29, 2008 EXT1 S SOU EXTENSION 1 FILED
Nov 13, 2007 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 21, 2007 PUBO A PUBLISHED FOR OPPOSITION
Aug 1, 2007 NPUB O NOTICE OF PUBLICATION
May 15, 2007 ALIE A ASSIGNED TO LIE
May 15, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 27, 2007 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 27, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 27, 2007 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 27, 2007 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 6, 2006 CNRT R NON-FINAL ACTION WRITTEN
Nov 6, 2006 GNRT F NON-FINAL ACTION E-MAILED
Nov 3, 2006 DOCK D ASSIGNED TO EXAMINER
Oct 10, 2006 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, pharmaceuticals for modulating calcium, phosphorus, or parathyroid hormone levels in the blood or for treatment of hyperparathyroidism, hypercalcemia or bone metabolism related disorders and diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...